Difficulty: Medium
Average Score: 64%
Practice
Which condition is associated with end-stage renal disease in pediatric patients and requires recombinant erythropoietin treatment?
Correct answer
D
Rationale
In pediatric patients with end-stage renal disease, anemia is a common complication due to decreased production of erythropoietin by the damaged kidneys. Recombinant erythropoietin is used to stimulate red blood cell production and treat anemia in these patients. Therefore, the correct answer is D) Anemia.
Option A) Osteodystrophy is associated with bone abnormalities in renal disease but does not directly require erythropoietin treatment. Option B) Hyperkalemia is high potassium levels and is managed with dietary restrictions and medications, not erythropoietin. Option C) Hypertension is a common complication of renal disease but is managed with antihypertensive medications.
Educationally, understanding the link between renal disease, anemia, and erythropoietin treatment is crucial for healthcare professionals caring for pediatric patients with end-stage renal disease. This knowledge helps in providing appropriate treatment and improving outcomes for these vulnerable patients. It also highlights the importance of monitoring and managing complications associated with renal disease in pediatric populations.
Option A) Osteodystrophy is associated with bone abnormalities in renal disease but does not directly require erythropoietin treatment. Option B) Hyperkalemia is high potassium levels and is managed with dietary restrictions and medications, not erythropoietin. Option C) Hypertension is a common complication of renal disease but is managed with antihypertensive medications.
Educationally, understanding the link between renal disease, anemia, and erythropoietin treatment is crucial for healthcare professionals caring for pediatric patients with end-stage renal disease. This knowledge helps in providing appropriate treatment and improving outcomes for these vulnerable patients. It also highlights the importance of monitoring and managing complications associated with renal disease in pediatric populations.